CRISTA JAMOUS: Open Payments
NPI 1710535794 · WEBSTER GROVES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $536 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Veozah, LEQVIO, REXULTI, Auvelity, JARDIANCE, SPRAVATO, BREZTRI, Ozempic.
Industry payments across MO — which companies pay providers there.
